Epstein-Barr virus-associated post-transplant lymphoproliferative disease during dasatinib treatment occurred 10 years after umbilical cord blood transplantation-Reference-Cited by-同舟云学术

Epstein-Barr virus-associated post-transplant lymphoproliferative disease during dasatinib treatment occurred 10 years after umbilical cord blood transplantation

Published:2021-07 Issue:7 Volume:27 Page:1076-1079
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Yamada Akiko^ORCID,Katagiri Seiichiro^ORCID,Moriyama Mitsuru,Asano Michiyo,Suguro Tamiko,Yoshizawa Seiichiro,Akahane Daigo,Tanaka Yuko,Furuya Nahoko,Fujimoto Hiroaki,Gotoh Moritaka,Aota Yasuo,Nakamura Naoya,Gotoh Akihiko^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference16 articles.

1. Post-transplantation lymphoproliferative disorders in adults;Dierickx;N Engl J Med,2018

2. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation;Romero;Leuk Lymphoma,2019

3. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation;Landgren;Blood,2009

4. Risk factors and predictive scoring system for post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation;Fujimoto;Biol Blood Marrow Transplant,2019

5. Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL;Saini;Blood,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spontaneous regression of dasatinib-related primary effusion lymphoma-like lymphoma;International Journal of Hematology;2022-09-06

2. Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial;BMC Medicine;2022-09-02

3. Dasatinib;Reactions Weekly;2021-08